A novel antibody based biomarker for toxicity of chronic domoic acid exposure
A novel antibody based biomarker for toxicity of chronic domoic acid exposure
批准号:
1314088
负责人:
David Marcinek
金额:
$130.46万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2019-01-31
中文摘要
神经毒性氨基酸软骨藻酸(DA)是有害藻华(HABs)期间自然产生的一种藻毒素,在食物网中的积累对人类和野生动物的健康构成重大威胁,并导致被称为失忆性贝类中毒(ASP)的神经毒性疾病。定期监测食用贝类组织中的DA水平对保护人类消费者免受急性高水平DA暴露是有效的。然而,对于长期低水平接触甲胺磷并没有任何保护措施,这可能对人类健康构成重大风险,特别是在沿海和部落社区,这些社区的生计捕捞贝类已知含有低水平的甲胺磷。由于全球藻类毒素暴露威胁日益增加,迫切需要快速可靠的诊断测试来评估人类和野生动物群体的慢性DA暴露,并需要证据来明确确定慢性DA暴露、生物标志物反应和健康影响之间的关系。在这项提案中,由华盛顿大学的一名科学家领导的研究小组将在小鼠模型系统中测试一种da特异性抗体的存在是慢性低水平暴露的生物标志物,这种抗体可能与亚临床健康影响有关。最近,该团队发现了(1)一种新的基于抗体的生物标志物,它是慢性低水平DA暴露和病理的特异性标志;(2)在斑马鱼慢性暴露模型中,慢性暴露会增加随后暴露的毒素敏感性。在研究中,具体目的是(1)测试小鼠慢性低水平DA暴露后抗体反应的时间和持续时间,(2)确定这种反应是否表明亚临床神经毒性,(3)测试先前暴露于DA是否影响随后的毒性易感性。新的见解将是,DA特异性抗体的存在是否是以前无法检测到的慢性DA暴露的可靠指标,进而是重大健康影响的准确预测指标。更广泛的影响:对于经常收获和食用贝类的沿海和部落社区成员来说,长期低水平暴露于DA是一个真正的问题。目前,评估人类接触的唯一方法是通过贝类消费调查。这项研究将是朝着开发可行的诊断测试以评估慢性低水平DA暴露对健康的影响迈出的重要的第一步,并将成为监测与海洋条件变化有关的暴露风险变化的重要工具。由NSF和NIEHS联合资助:该项目的原始提案(R01 ES021930-01)是根据资助机会公告RFA-ES-11-013,“海洋,大湖和人类健康(R01)”提交给国家环境健康科学研究所(NIH/NIEHS)的,这是一个由NSF联合赞助的机会。本项目由NSF和NIEHS分别合作资助。
英文摘要
Accumulation of the neurotoxic amino acid domoic acid (DA), a phycotoxin naturally produced during harmful algal blooms (HABs), in the food web poses significant health threats to humans and wildlife and is responsible for a neurotoxic illness known as amnesic shellfish poisoning (ASP). Regular monitoring of DA levels in edible shellfish tissues has been effective in protecting human consumers from acute high-level DA exposure. However, there is no protection from chronic low-level DA exposure, which may pose significant human health risks, particularly in coastal and tribal communities that subsistence harvest shellfish known to contain low levels of the toxin. Due to increasing algal toxin exposure threats globally, there is a critical need for rapid and reliable diagnostic tests for assessing chronic DA exposure in human and wildlife populations, and for evidence that clearly establishes the relationship between chronic DA exposure, biomarker response, and health impacts.In this proposal a research team led by a scientist at the University of Washington will test the hypothesis that the presence of a DA-specific antibody is a biomarker for chronic low-level exposure that can be linked to subclinical health impacts in a mouse model system. Recently, this team has discovered (1) a novel antibody based biomarker that is a specific signature for chronic low-level DA exposure and pathology, and (2) that chronic exposure increases toxin susceptibility in subsequent exposures in a zebrafish chronic exposure model. In study the specific objectives are (1) to test the timing and duration of the antibody response following chronic, low-level DA exposure in mice, (2) to determine whether this response is indicative of subclinical neurotoxicity, and (3) to test whether previous exposures to DA affect subsequent toxic susceptibility. The new insight will be whether the presence of a DA-specific antibody is a reliable indicator of previously undetectable chronic DA exposures, and in turn an accurate predictor of significant health effects. Broader Impacts: Chronic, low-level exposure to DA is a genuine concern for members of coastal and tribal communities who routinely harvest and consume shellfish. Currently, the only way to assess exposure in humans is through shellfish consumption surveys. This study will be an important first step towards developing a viable diagnostic test for assessing health impacts of chronic low-level DA exposure and will be an important tool for monitoring changes in exposure risks associated with changing ocean conditions.JOINT FUNDING BY NSF AND NIEHS: The original proposal on which this project is based (R01 ES021930-01) was submitted to the National Institutes of Environmental Health Sciences (NIH/NIEHS) in response to Funding Opportunity Announcement RFA-ES-11-013 , "Oceans, Great Lakes and Human Health (R01)", an opportunity jointly sponsored by NSF. This project is cooperatively funded through separate awards from NSF and NIEHS.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
-
批准号:1839041
-
项目类别:Continuing Grant
-
资助金额:$97.84万
-
财政年份:2018
-
负责人:David Marcinek
-
依托单位:
国内基金
海外基金
CD8+T细胞亚群在抗MDA5抗体阳性皮肌炎中的致病机制研究
-
批准号:82371805
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:扶琼
-
依托单位:
沙眼衣原体pORF5蛋白功能及其与宿主细胞相互作用的研究
-
批准号:30970165
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:李忠玉
-
依托单位: